Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.1 | uM | 8 | 156.25 | 28.44 | 121.00 | 84.75 | 1.4277 | 1.5072 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 112.00 | 84.75 | 1.3215 | 1.3872 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 156.25 | 28.44 | 97.00 | 84.75 | 1.1445 | 1.1789 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 28.44 | 111.00 | 84.75 | 1.3097 | 1.3736 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 156.25 | 28.44 | 70.00 | 84.75 | 0.8260 | 0.7714 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 98.00 | 84.75 | 1.1563 | 1.1932 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 108.00 | 84.75 | 1.2743 | 1.3327 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 156.25 | 28.44 | 51.00 | 84.75 | 0.6018 | 0.4489 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 99.00 | 84.75 | 1.1681 | 1.2074 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 156.25 | 28.44 | 75.00 | 84.75 | 0.8850 | 0.8507 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 28.44 | 100.00 | 84.75 | 1.1799 | 1.2215 |
| BT-20 | Lapatinib | 1 | uM | 8 | 156.25 | 28.44 | 97.00 | 84.75 | 1.1445 | 1.1789 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 96.00 | 84.75 | 1.1327 | 1.1647 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 57.00 | 84.75 | 0.6726 | 0.5548 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 190.00 | 204.75 | 0.9280 | 0.7872 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 145.00 | 204.75 | 0.7082 | 0.1900 | |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 312.50 | 129.17 | 178.00 | 204.75 | 0.8694 | 0.6201 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 191.00 | 204.75 | 0.9328 | 0.8014 |
| BT-20 | Linsitinib | 10 | uM | 8 | 312.50 | 129.17 | 197.00 | 204.75 | 0.9622 | 0.8872 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 312.50 | 129.17 | 287.00 | 204.75 | 1.4017 | 2.3242 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 254.00 | 204.75 | 1.2405 | 1.7661 |
| BT-20 | Erlotinib | 1 | uM | 8 | 312.50 | 129.17 | 285.00 | 204.75 | 1.3919 | 2.2894 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 312.50 | 129.17 | 203.00 | 204.75 | 0.9915 | 0.9743 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 283.00 | 204.75 | 1.3822 | 2.2548 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 312.50 | 129.17 | 255.00 | 204.75 | 1.2454 | 1.7825 |